Karen L. Smith - Insider Trading & Ownership

Entity
Individual
Location
C/O Jazz Pharmaceuticals Plc, 5 Th Fl, Waterloo Exchange, Waterloo Rd, Dublin L2 4, Ireland
Summary
The estimated net worth of Karen L. Smith is at least $251 K dollars as of July 5, 2024. Karen L. Smith is the Chief Medical Officer of Quince Therapeutics, Inc. and owns shares of Quince Therapeutics, Inc. (QNCX) stock worth about $183 K. Karen L. Smith is the Director of SANGAMO THERAPEUTICS, INC and owns shares of SANGAMO THERAPEUTICS, INC (SGMO) stock worth about $46.3 K. Karen L. Smith is the EVP, Chief Medical Officer of Emergent BioSolutions Inc. and owns shares of Emergent BioSolutions Inc. (EBS) stock worth about $21.6 K.
All Insider Reports
All Insider Reports

Ownership of Karen L. Smith

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
QNCX Quince Therapeutics, Inc. Chief Medical Officer $183 K Feb 1, 2023
SGMO SANGAMO THERAPEUTICS, INC Director $46.3 K Jun 4, 2024
EBS Emergent BioSolutions Inc. EVP, Chief Medical Officer $21.6 K May 7, 2021
XLRN ACCELERON PHARMA INC Director Nov 19, 2021
ATRS ANTARES PHARMA, INC. Director May 24, 2022
AUPH Aurinia Pharmaceuticals Inc. Director Aug 18, 2023
SKYE Skye Bioscience, Inc. Director Jul 2, 2024
TRML Tourmaline Bio, Inc. Director Jun 13, 2023

Insider Transactions Reported by Karen L. Smith:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership